ES2061394B1 - MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT. - Google Patents
MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT.Info
- Publication number
- ES2061394B1 ES2061394B1 ES9300218A ES9300218A ES2061394B1 ES 2061394 B1 ES2061394 B1 ES 2061394B1 ES 9300218 A ES9300218 A ES 9300218A ES 9300218 A ES9300218 A ES 9300218A ES 2061394 B1 ES2061394 B1 ES 2061394B1
- Authority
- ES
- Spain
- Prior art keywords
- potassic
- granulate
- citrate
- manufacturing procedure
- delayed assignment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 title abstract 3
- 230000003111 delayed effect Effects 0.000 title abstract 3
- 239000008187 granular material Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- ZDPXQHOIMJIDFG-UHFFFAOYSA-J dicalcium oxalate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O ZDPXQHOIMJIDFG-UHFFFAOYSA-J 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
PROCEDIMIENTO DE FABRICACION DE UN GRANULADO DE CITRATO POTASICO CON CESION RETARDADA. CONSISTE EN LA PREPARACION DE UN GRANULADO DE CITRATO POTASICO, EL CUAL ES UTIL PARA LA POSTERIOR PREPARACION DE DIVERSAS FORMAS FARMACEUTICAS, PREFERENTEMENTE COMPRIMIDOS, QUE SE EMPLEAN PARA EVITAR LA FORMACION DE CALCULOS RENALES DE OXALATO CALCICO, FOSFATO CALCICO O ACIDO URICO. ASIMISMO, FAVORECE LA CESION RETARDADA DEL PRINCIPIO ACTIVO, CON EL FIN DE QUE EL EFECTO TERAPEUTICO SE MANTENGA ESTABLE A LO LARGO DEL TIEMPO Y PUEDA DISMINUIRSE EL NUMERO DE ADMINISTRACIONES.MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT. IT CONSISTS IN THE PREPARATION OF A POTASSIC CITRATE GRANULATE, WHICH IS USEFUL FOR THE SUBSEQUENT PREPARATION OF DIFFERENT PHARMACEUTICAL FORMS, PREFERABLY COMPRESSED, THAT ARE USED TO AVOID THE FORMATION OF KIDNEY CALCIUM OXALATE CALCIUM, PHOSPHATE ACID FURTHER, IT DELIVERS THE DELAYED ASSIGNMENT OF THE ACTIVE SUBSTANCE, IN ORDER THAT THE THERAPEUTIC EFFECT REMAINS STABLE OVER TIME AND THE NUMBER OF ADMINISTRATIONS MAY BE DECREASED.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9300218A ES2061394B1 (en) | 1993-02-05 | 1993-02-05 | MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9300218A ES2061394B1 (en) | 1993-02-05 | 1993-02-05 | MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2061394A1 ES2061394A1 (en) | 1994-12-01 |
| ES2061394B1 true ES2061394B1 (en) | 1995-06-16 |
Family
ID=8280688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES9300218A Expired - Fee Related ES2061394B1 (en) | 1993-02-05 | 1993-02-05 | MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2061394B1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070077314A1 (en) * | 2005-07-15 | 2007-04-05 | Pak Charles Y C | Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis |
| FR3009496B1 (en) * | 2013-08-12 | 2016-02-05 | Mohamed Skiba | MULTIPARTICULAR FORMS WITH PROLONGED RELEASE, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME FOR THE TREATMENT AND / OR PREVENTION OF CYCTINURIA |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1312918A (en) * | 1969-07-08 | 1973-04-11 | Beecham Group Ltd | Veterinary treatment |
| DE2426811A1 (en) * | 1974-06-04 | 1976-01-08 | Klinge Co Chem Pharm Fab | PROCESS FOR THE MANUFACTURING OF RETARD TABLETS |
| HU190619B (en) * | 1983-11-11 | 1986-09-29 | Bezzegh,Denes,Hu | Process for producing tablets with controlled dissolution of active ingredients |
| FR2581541B1 (en) * | 1985-05-09 | 1988-05-20 | Rhone Poulenc Sante | NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE EXTENDED RELEASE OF AN ACTIVE INGREDIENT AND THEIR PREPARATION METHOD |
-
1993
- 1993-02-05 ES ES9300218A patent/ES2061394B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2061394A1 (en) | 1994-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2194013T3 (en) | PHARMACEUTICALLY FIXED HUMAN DRYING BLOOD PLATES | |
| BR0003158A (en) | Instant melting oral dosage formulation | |
| PA8438801A1 (en) | SUBSTITUTE FOR MILK AND PROCESS FOR ITS MANUFACTURE | |
| KR850007559A (en) | Implantable Formulations of Regulatory Peptides | |
| UA66847C2 (en) | Solid rapidly decomposing fizzy dosage form of selegiline and method for its production | |
| SV2004001556A (en) | ACID PREPARATIONS OF INSULIN WITH IMPROVED STABILITY | |
| AR245369A1 (en) | New medicaments for topical use | |
| BR9714509A (en) | Solid formulations containing trehalose | |
| KR910014120A (en) | Oral Pharmaceutical Formulations of Fimovevenan | |
| MX9401211A (en) | COMPOSITION AND PROCEDURE TO COMBAT AGROMERATION OF FERTILIZERS. | |
| ES2061394B1 (en) | MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT. | |
| AR006892A1 (en) | USE OF FORMS OF HYALURONIC ACID (HA) FOR THE TREATMENT OF CANCER | |
| DE3888739D1 (en) | Submunition active part, as well as Flechettes warhead and Flechettes therefor. | |
| FI832098A7 (en) | Metronidazole N,N-dimethylglycine ester and its acid addition salt. | |
| FR2044216A5 (en) | Effervescent tablets prepd by aqueous - granulation | |
| RU99116432A (en) | METHOD FOR IMMOBILIZING PHYSIOLOGICALLY ACTIVE COMPOUNDS | |
| FR2338705B1 (en) | ||
| SU432098A1 (en) | ||
| MY101266A (en) | Pharmaceutical formulations | |
| JPS5366422A (en) | Mixed insecticide composition | |
| PE20010825A1 (en) | A PHARMACEUTICAL COMPOSITION THAT HAS GREAT PERMEABILITY THROUGH THE CELLULAR MEMBRANE | |
| BG30916A3 (en) | Insecticide means and method for insects fighting | |
| JPS53135930A (en) | Preparation of magnesium salt of sulfonic acid ester or sulfuric acid ester | |
| JPS5285061A (en) | Removal of fluorine ions in solution containing conc. silicic acid | |
| BR8406512A (en) | PHOSPHORIC ACID ESTER, PROCESS FOR ITS PRODUCTION AND PESTICIDE COMPOSITION CONTAINING IT AS AN ACTIVE INGREDIENT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD2A | Announcement of lapse in spain |
Effective date: 20180806 |